Periodontal Therapeutics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

MARKET INTRODUCTION
Periodontal therapeutics are products used in treatment of periodontal disease. Periodontitis is chronic bacterial infection caused due to microbial plaque often known as gum disease, which is colonized on tooth surface and below the gingival margin. Periodontal disease are caused due to hormonal changes, smoking, poor oral health hygiene and some hereditary factors. The periodontal disease involves progressive loss of alveolar bone and majorly observed in adults.

MARKET DYNAMICS
The global periodontal therapeutics market is expected to grow due to rise in geriatric population, increase in prevalence of periodontal disease due to changing lifestyle, increased tooth retention which leads to periodontitis, reduced side effect of drugs, low dose requirement for treatment and others. On the other hand advancement in treatment by using novel drug and increase in preference to local drug for treatment of periodontal disease are expected to offer new opportunities in market growth.

MARKET SCOPE
The "Global Periodontal Therapeutics Market Analysis to 2031" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of periodontal therapeutics market with detailed market segmentation by drug type, distribution channel and geography. The global periodontal therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading periodontal therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global periodontal therapeutics market is segmented on the basis of drug type and distribution channel Based on drug type, the market is segmented as arestin, atridox, doxycycline, metronidazole, minocycline, periochip and others. Based on distribution channel the market is segmented as hospital pharmacies, retail pharmacies and online channel REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global periodontal therapeutics market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The periodontal therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting periodontal therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the periodontal therapeutics market in these regions.

Periodontal Therapeutics Market Report Analysis

Periodontal Therapeutics Market

• 
  CAGR (2023 - 2031)

  XX%
• Market Size 2023
  US$ XX Million
• Market Size 2031
  US$ XX Million

Report Coverage

• Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope

• Key future trends
• Detailed PEST/Porter’s Five Forces and SWOT analysis

• Industry landscape and competition analysis & recent developments
• Detailed company profiles

• Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

• Tolmar Pharmaceuticals, Inc.
• Eli Lilly and Company
• Align Technology, Inc.
• 3M
• Ultradent Products Inc.
• Nobel Biocare Services AG
• Glidewell Laboratories
• Den-Mat Holdings, LLC
• Mallinckrodt.

Regional Overview

• North America
• Europe
• Asia-Pacific
• South and Central America
• Middle East and Africa

Market Segmentation

By Drug Type

• Arestin
• Atridox
• Doxycycline
• Metronidazole
• Minocycline
• Periochip

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Channel

MARKET PLAYERS
The reports cover key developments in the periodontal therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from periodontal therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for periodontal therapeutics in the global market. Below mentioned is the list of few companies engaged in the periodontal therapeutics market.

The report also includes the profiles of key periodontal therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Tolmar Pharmaceuticals, Inc.
• Eli Lilly and Company
• Align Technology, Inc.
• 3M
• Ultradent Products Inc.
• Nobel Biocare Services AG
• Glidewell Laboratories
• Den-Mat Holdings, LLC
• Mallinckrodt.
• Teva Pharmaceutical Industries Ltd

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Periodontal Therapeutics Market Report Scope